Related Experiment Videos
Gene transfer to somatic tissues using retroviral vectors
P Moullier1, V Marechal, N Ferry
1Laboratoire Rétrovirus et Transfert Génétique, Institut Pasteur, Département SIDA/Rétrovirus, Paris, France.
Nouvelle Revue Francaise D'Hematologie
|January 1, 1991
Summary
This study demonstrates stable gene transfer in mice using retroviral vectors to correct a genetic defect causing mucopolysaccharidosis. This research advances gene therapy for inherited diseases.
Area of Science:
- Genetics
- Molecular Biology
- Gene Therapy
Background:
- Retroviral vectors enable stable gene transfer for in vivo applications.
- Animal models are crucial for validating gene therapy approaches for human genetic diseases.
- Mucopolysaccharidosis is a genetic disorder caused by beta-glucuronidase deficiency.
Purpose of the Study:
- To evaluate retroviral vector-mediated gene transfer in a mouse model of mucopolysaccharidosis.
- To demonstrate the correction of pathological symptoms through stable gene introduction.
Main Methods:
- Utilized a mouse strain with the gusmps mutation, exhibiting beta-glucuronidase deficiency.
- Developed methods for stable gene transfer of human beta-glucuronidase cDNA into skin fibroblasts and hematopoietic stem cells.
- Investigated a method for stable gene transfer to the liver.
Main Results:
- Successfully achieved stable introduction of the beta-glucuronidase cDNA into target cells.
- The methods presented facilitate gene correction in a relevant animal model.
Conclusions:
- Retroviral vector-mediated gene transfer is a viable strategy for treating genetic disorders like mucopolysaccharidosis.
- This study provides a foundation for applying gene therapy to human genetic diseases.